Thyroid Nodule Molecular Testing

Molecular testing of thyroid nodules is covered once per nodule when FNA was performed for established ultrasound/clinical indications and the cytology is indeterminate (Bethesda III or IV), the decision for thyroidectomy remains unclear, institutional malignancy rates are known, and the informed patient is willing to consider surveillance. Coverage is limited to tests submitted to NGS jurisdictions J6 and JK and is not indicated for nodules with clearly benign or malignant cytology or when surgery is already decided.

"Thyroid fine-needle aspiration (FNA) was performed for established indications based on ultrasound characteristics, nodule size, and clinical findings."

Sign up to see full coverage criteria, indications, and limitations.